Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H15N5O3S |
| Molecular Weight | 309.344 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(C)N=C(NC(=N)NS(=O)(=O)C2=CC=C(N)C=C2)O1
InChI
InChIKey=IJZUQDQOAFUFJY-UHFFFAOYSA-N
InChI=1S/C12H15N5O3S/c1-7-8(2)20-12(15-7)16-11(14)17-21(18,19)10-5-3-9(13)4-6-10/h3-6H,13H2,1-2H3,(H3,14,15,16,17)
| Molecular Formula | C12H15N5O3S |
| Molecular Weight | 309.344 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1199161
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1199161
Sulfaguanol (Enterocura), an antibacterial sulfanilamide drug that was used for patients with acute diarrhea
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Tolerance and effect of Sulfaguanol (Enterocura)]. | 1974-10-18 |
|
| [Synthesis and chemical properties of sulfaguanol]. | 1973-02 |
|
| [Pharmacokinetics of sulfaguanol in repeated oral administration in the human]. | 1973-02 |
|
| [Intestinal absorption of sulfaguanol in children]. | 1973-02 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4739826
Unknown
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:26:21 GMT 2025
by
admin
on
Mon Mar 31 18:26:21 GMT 2025
|
| Record UNII |
0X9P7B60UD
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29739
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
27031-08-9
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY | |||
|
2506
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY | |||
|
m10311
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY | Merck Index | ||
|
C72850
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY | |||
|
0X9P7B60UD
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107223
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY | |||
|
2874
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY | |||
|
65756
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY | |||
|
100000083268
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY | |||
|
SUB10704MIG
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY | |||
|
DTXSID0023610
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY | |||
|
248-175-4
Created by
admin on Mon Mar 31 18:26:21 GMT 2025 , Edited by admin on Mon Mar 31 18:26:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |